These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 7853924)
21. Competition and antitrust enforcement in the changing pharmaceutical marketplace. Whitener MD Food Drug Law J; 1995; 50(2):301-7. PubMed ID: 10342998 [No Abstract] [Full Text] [Related]
22. The Hatch-Waxman Act: balancing competing interests or survival of the fittest? Behrendt KE Food Drug Law J; 2002; 57(2):247-71. PubMed ID: 12436990 [No Abstract] [Full Text] [Related]
23. [Drug turnover and the European Community]. Botvar PK Tidsskr Nor Laegeforen; 1993 Jun; 113(16):2021-4. PubMed ID: 8322362 [No Abstract] [Full Text] [Related]
24. Who's really raising drug prices? Zagorin A Time; 1999 Mar; 153(9):46-8. PubMed ID: 10346086 [No Abstract] [Full Text] [Related]
25. Generics battle brand names over mortality of drug patents. Betz R J Healthc Resour Manag; 1995 Jul; 13(7):35-7. PubMed ID: 10144008 [No Abstract] [Full Text] [Related]
26. Effect of drug industry marketing practices on formularies questioned by federal agencies. Gatty B Hosp Formul; 1994 Nov; 29(11):786, 785. PubMed ID: 10138576 [No Abstract] [Full Text] [Related]
27. Hoechst plans divestitures to gain FTC nod. Scott L Mod Healthc; 1995 Sep; 25(39):32. PubMed ID: 10151416 [No Abstract] [Full Text] [Related]
28. Health and intellectual property rights. Correa CM Bull World Health Organ; 2001; 79(5):381. PubMed ID: 11417031 [No Abstract] [Full Text] [Related]
29. Amgen's NESP victory cuts out Johnson & Johnson. Fürst I Nat Biotechnol; 1999 Feb; 17(2):124. PubMed ID: 10052335 [No Abstract] [Full Text] [Related]
30. [Parallel import of drugs]. Rygnestad T; Fredriksen G; Spigset O Tidsskr Nor Laegeforen; 1999 Apr; 119(11):1573. PubMed ID: 10385794 [No Abstract] [Full Text] [Related]
36. Expanded EU presents promise and challenges. Vermij P Nat Rev Drug Discov; 2004 May; 3(5):377-8. PubMed ID: 15152627 [No Abstract] [Full Text] [Related]
37. Pharmaceutical policy in Italy: towards a structural change? Ghislandi S; Krulichova I; Garattini L Health Policy; 2005 Apr; 72(1):53-63. PubMed ID: 15760698 [TBL] [Abstract][Full Text] [Related]
38. EU launches measures to stop diversion of cut-price drugs. Fleck F Bull World Health Organ; 2003; 81(7):549. PubMed ID: 12973652 [No Abstract] [Full Text] [Related]
39. New EU antitrust law burdens licensing. Louët S Nat Biotechnol; 2004 Jun; 22(6):643. PubMed ID: 15175670 [No Abstract] [Full Text] [Related]
40. Lilly deal's timing drew FTC notice. Scott L Mod Healthc; 1994 Oct; 24(43):8. PubMed ID: 10138136 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]